Zhao, W. L., Zhu, J., Xu, P., Song, Y., Shen, J., Cai, Q., Zhou, H., Zhang, L., Xiang, Y., Sun, X., Yang, W., Yao, Z., Jing, H., Wen, S., Jin, J., Xue, H., Cen, H., Ding, K., Jin, Z., Liu, L., Xing, X., Li, L., Hou, M., Liu, L., Zhang, M., Li, W., Bai, O., Feng, R., Zhu, Z., Wu, H., Su, L., Gao, L., Li, F., Huang, W., Liu, P., Yan, X., Zhao, Y., Su, H., Zhao, X., Fu, R., Liu, H., Shi, W. (2025). Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study. Blood. https://doi.org/10.1182/blood-2025-475